🎁Capturing Top 10 Ex_dividend: WSO, GHC, PNC, ABBV, MAA...

Tiger_Earnings
07-15

1.Which High Ex-dividend Stock (on 15 July ~ 19 July) do You Like the Most?

Be Sure To Check Out the Last Chance to Buy the Top 10 High dividend stocks going to Ex-dividends This Week: many companies like $Watsco(WSO)$ and $Graham(GHC)$ showing below are about to give decent dividends into "your pocket".

Editor's notes:

A dividend-paying stock ex-dividend date, or ex-date, is very important to investors. In a nutshell, if you buy a dividend stock before the ex-dividend date, then you will receive the next upcoming dividend payment. If you purchase the stock on or after the ex-dividend date, you will not receive the dividend. Some investors utilize strategies whereby they will purchase stocks just prior to an ex-dividend date and sell shortly thereafter.

2.YTD24 of the Above 10 Stocks are as Below:

According to the data chart on TradingView, $Watsco(WSO)$ , $Graham(GHC)$ , $PNC Financial Services Group Inc(PNC)$ , $AbbVie(ABBV)$, $Mid-America Apartment Communities(MAA)$ , $EOG Resources(EOG)$ , $American(AFG)$ , $Owens-Corning(OC)$ are seeing gains in 2024. $City(CHCO)$ and $Saul Centers(BFS)$ are showing losses for the year 2024.

3.Reply to Win Tiger Coins

  • Which stock above do you like the most? Why?

  • Please find the Analyst Price Target of the mentioned stocks from Tiger Trade "Analysis".

  • Any other companies going to ex_dividend this week you are interested in?

🎁Prizes

  • 🐯 All valid comment on the following post will receive 5 Tiger Coins.

  • 🐯 The Top 3 comments with the most likes will get another 10 Tiger Coins.

# 💰 Stocks to watch today?(06 Sep)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（12）

  • Top
  • Latest
  • icycrystal
    ·07-16
    TOP
    oh wow, $AbbVie(ABBV)$ divided is quite a fair bit [Miser]

    a stock to consider if looking for dividend stock... but take caution to its business fundamentals as it's still the most important thing to know if the business can grow and keep up the good dividend [Miser]

    @rL @Shyon @Aqa @LMSunshine @koolgal @GoodLife99 @Universe宇宙 @SPACE ROCKET @TigerGPT @HelenJanet

    Which stock above do you like the most? Why?


    Please find the Analyst Price Target of the mentioned stocks from Tiger Trade "Analysis".


    Any other companies going to ex_dividend this week you are interested in?


    🎁Prizes

    🐯 All valid comment on the following post will receive 5 Tiger Coins.

    Reply
    Report
    Fold Replies
    • SPACE ROCKET: 
      Yes I've been looking to add Abvie but then it's too pricey. It used to be in the 80s region during covid + Ukraine war!
      07-16
      Reply
      Report
    • TigerGPT: 

      AbbVie (ABBV) Valuation Analysis

      Long-term Valuation:

      Analyst Target Price: According to 25 analysts, the mean target price for AbbVie is $184.12, with a low estimate of $170.00 and a high estimate of $203.00.  

      Analyst Recommendation: Out of the 25 analysts, 4 recommend, 17 buy, and 9 hold AbbVie stock.  

      Short-term Valuation:

      Stock Price: As of July 16, 2024, AbbVie's stock price is $168.03.  

      Support Price: The support price on July 12, 2024, was $170.18.  

      Resistance Price: The resistance price on July 12, 2024, was $170.28.  

      Average Cost: The average cost on July 12, 2024, was $165.09.  

      Business Fundamentals:

      Earnings Result: In Q1 2024, AbbVie reported an EPS of $0.77, a return on equity of 59.19%, and a gross profit margin of 67.38%.  

      Earnings Forecast: For the fiscal year 2024, AbbVie is forecasted to have an EPS of $10.74, gross income of $55.21 billion, and EBIT of $24.65 billion. For the fiscal year 2025, the forecasted EPS is $12.05, gross income is $58.58 billion, and EBIT is $27.60 billion. For the fiscal year 2026, the forecasted EPS is $13.43, gross income is $62.88 billion, and EBIT is $30.45 billion.  

      Capital Flow Analysis:

      5-Day Capital Flow: From July 8 to July 12, 2024, the capital flow for AbbVie was as follows:

      July 8: -$8,171.04 thousand units  

      July 9: $13,465.39 thousand units  

      July 10: -$10,429.00 thousand units  

      July 11: -$13,631.14 thousand units  

      July 12: -$33,408.89 thousand units  

        

      1-Day Capital Flow: On July 16, 2024, the inflow was $100,762,686.86, and the outflow was $87,823,343.66. The big inflow was $15.12 million, the median inflow was $5.69 million, and the small inflow was $79.96 million. The big outflow was $5.84 million, the median outflow was $5.63 million, and the small outflow was $76.36 million.  

      Conclusion:Based on the valuation analysis, AbbVie has a mean target price of $184.12 according to analysts. The stock is currently trading at $168.03, with a support price of $170.18 and a resistance price of $170.28. The company's business fundamentals, including earnings results and forecasts, indicate potential growth. However, it is important to consider the overall business fundamentals and growth prospects before making any investment decisions.

      Disclaimer:The above analysis is for informational purposes only and should not be considered as investment advice. Investors should conduct their own research and analysis before making any investment decisions. The stock market is subject to risks, and past performance is not indicative of future results.

      07-16
      Reply
      Report
  • Aqa
    ·07-16
    $AbbVie(ABBV)$ is my top favorite. This pharmaceutical company gives annual dividend yield of 3.67% and the stock price growth 6.54% year to date. ABBV share price is trending up now. Catch it while you can. Thanks @Tiger_Earnings @icycrystal [Heart][Heart][Heart]
    Reply
    Report
  • 1PC
    ·07-17
    $AbbVie(ABBV)$ The 10Div stocks are all Uptrend 📈. I picked Abbv as has a friend who uses to work in this company 😄. It is still a Strong pharmaceutical counter to look out for [Miser] [Miser]
    Reply
    Report
  • MHh
    ·07-15
    Abbvie should be able to do well but given the likes of Eli Lilly, no reason to buy this. Not really interested in the rest
    Reply
    Report
    Fold Replies
  • Success88
    ·07-15
    Support $AbbVie(ABBV)$ dividend good and potential of growth in long term.
    Reply
    Report
  • nomadic_m
    ·07-17
    $Watsco(WSO)$ is high dividend & high growth. what is there not to like?
    Reply
    Report
  • SPACE ROCKET
    ·07-16
    $AbbVie(ABBV)$ would be my top pick from the list.
    Reply
    Report
  • MasterStonker
    ·07-15
    ABBV is like Warren's fav stock
    Reply
    Report
  • Agxm
    ·07-18
    Ok
    Reply
    Report